2025年岁末,中国生物医药产业的全球化进程迎来关键节点:医药魔方NextPharma数据库显示,创新药出海授权(License-out)全年交易总额达到1356.55亿美元(为2024年的2.5倍),首付款70亿美元,交易总量157起,各项数据均创历史新高。这组数字背后,是中国创新药企正在经历的一场深刻转型——从早期以技术授权为主的“出海1.0”,步入合作模式多元化、里程碑密集兑现、全球价值获...
Source Link2025年岁末,中国生物医药产业的全球化进程迎来关键节点:医药魔方NextPharma数据库显示,创新药出海授权(License-out)全年交易总额达到1356.55亿美元(为2024年的2.5倍),首付款70亿美元,交易总量157起,各项数据均创历史新高。这组数字背后,是中国创新药企正在经历的一场深刻转型——从早期以技术授权为主的“出海1.0”,步入合作模式多元化、里程碑密集兑现、全球价值获...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.